Purpose: This study was performed to evaluate the safety and efficacy of midazolam in asthmatic patients undergoing dental treatment.
Methods: Twenty-four children, aged 19 to 65 months, with a diagnosis of mild to moderate asthma were given an oral dose of 0.5 mg/kg of midazolam.